Anna F. Farago, MD, PhD
Advertisement
Articles by Anna F. Farago, MD, PhD
Cancer Network spoke with Anna F. Farago, MD, of Massachusetts General Hospital, about the effect of trilaciclib on myelosuppression in patients with previously treated extensive-stage small-cell lung cancer receiving topotecan.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
The Moonlight Shift: Dr Joshua Richter on Myeloma, Myths, and the C-Word
2
Current Treatment Landscape of HER2-Positive Metastatic Breast Cancer and Phase 3 Trial Overview
3
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
4
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
5